First Quadrant’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-20,475
| Closed | -$4.61M | – | 158 |
|
|
2021
Q4 | $4.61M | Hold |
20,475
| – | – | 0.5% | 34 |
|
|
2021
Q3 | $4.35M | Hold |
20,475
| – | – | 0.51% | 33 |
|
|
2021
Q2 | $4.99M | Sell |
20,475
-2,280
| -10% | -$561K | 0.57% | 25 |
|
|
2021
Q1 | $5.66M | Sell |
22,755
-1,072
| -4% | -$256K | 0.6% | 22 |
|
|
2020
Q4 | $5.48M | Sell |
23,827
-2,859
| -11% | -$659K | 0.55% | 22 |
|
|
2020
Q3 | $6.78M | Sell |
26,686
-3,037
| -10% | -$752K | 0.87% | 14 |
|
|
2020
Q2 | $7.01M | Buy |
29,723
+3,037
| +11% | +$693K | 0.94% | 15 |
|
|
2020
Q1 | $5.41M | Hold |
26,686
| – | – | 0.79% | 21 |
|
|
2019
Q4 | $6.43M | Hold |
26,686
| – | – | 0.54% | 37 |
|
|
2019
Q3 | $5.16M | Sell |
26,686
-42,041
| -61% | -$8.07M | 0.49% | 45 |
|
|
2019
Q2 | $12.7M | Sell |
68,727
-1,026
| -1% | -$184K | 0.88% | 14 |
|
|
2019
Q1 | $13.3M | Sell |
69,753
-2,048
| -3% | -$391K | 1.02% | 16 |
|
|
2018
Q4 | $14M | Buy |
71,801
+700
| +1% | +$137K | 1.13% | 13 |
|
|
2018
Q3 | $14.7M | Sell |
71,101
-49,255
| -41% | -$9.71M | 0.33% | 120 |
|
|
2018
Q2 | $22.2M | Sell |
120,356
-38,318
| -24% | -$6.78M | 0.42% | 85 |
|
|
2018
Q1 | $27.1M | Sell |
158,674
-155,391
| -49% | -$28.5M | 0.52% | 47 |
|
|
2017
Q4 | $54.6M | Buy |
314,065
+154,499
| +97% | +$27.3M | 1.03% | 8 |
|
|
2017
Q3 | $29.8M | Sell |
159,566
-168,957
| -51% | -$29.9M | 0.58% | 29 |
|
|
2017
Q2 | $56.6M | Buy |
328,523
+146,396
| +80% | +$23.8M | 1.13% | 5 |
|
|
2017
Q1 | $29.9M | Sell |
182,127
-146,909
| -45% | -$24.4M | 0.59% | 29 |
|
|
2016
Q4 | $48.1M | Sell |
329,036
-18,557
| -5% | -$2.79M | 0.99% | 6 |
|
|
2016
Q3 | $58M | Buy |
347,593
+195
| +0.1% | +$33K | 1.23% | 5 |
|
|
2016
Q2 | $52.9M | Sell |
347,398
-391
| -0.1% | -$60.8K | 1.17% | 9 |
|
|
2016
Q1 | $52.1M | Buy |
347,789
+9,900
| +3% | +$1.47M | 1.14% | 9 |
|
|
2015
Q4 | $54.9M | Sell |
337,889
-23,562
| -7% | -$3.7M | 1.2% | 8 |
|
|
2015
Q3 | $50M | Buy |
361,451
+10,525
| +3% | +$1.66M | 1.12% | 14 |
|
|
2015
Q2 | $53.9M | Buy |
350,926
+14,100
| +4% | +$2.26M | 1.13% | 13 |
|
|
2015
Q1 | $53.8M | Buy |
336,826
+11,193
| +3% | +$1.76M | 1.12% | 14 |
|
|
2014
Q4 | $51.9M | Buy |
325,633
+137,700
| +73% | +$21.5M | 1.09% | 13 |
|
|
2014
Q3 | $26.4M | Buy |
187,933
+78,066
| +71% | +$10.2M | 0.59% | 48 |
|
|
2014
Q2 | $13M | Sell |
109,867
-185,019
| -63% | -$21.4M | 0.29% | 107 |
|
|
2014
Q1 | $36.4M | Sell |
294,886
-120
| -0% | -$14.6K | 0.83% | 25 |
|
|
2013
Q4 | $33.7M | Sell |
295,006
-39
| -0% | -$4.44K | 0.79% | 29 |
|
|
2013
Q3 | $33M | Sell |
295,045
-38
| -0% | -$4.12K | 0.84% | 22 |
|
|
2013
Q2 | $29.1M | Buy |
+295,083
| New | +$30.6M | 0.78% | 25 |
|
Other funds holding AMGN
First Quadrant's AMGN Position: Q1 2022 in Review
First Quadrant sold out of Amgen (AMGN) in Q1 2022, closing a stake of 20,475 shares — an estimated $4.61M sold.
First Quadrant first reported a position in AMGN in Q2 2013 and held it in 35 quarters. The position peaked at $58M in Q3 2016. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.
- First Quadrant reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
- First Quadrant sold 20,475 Amgen shares in Q1 2022, an estimated $4.61M.
- First Quadrant first reported a position in Amgen in Q2 2013 and held it in 35 quarters.
- First Quadrant's Amgen position peaked at $58M in Q3 2016.
- 2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.
Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.